OTC Pharmaceuticals: Global Industry Almanac, MarketLine

News provided by

May 02, 2012, 07:30 ET

NEW YORK, May 2, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

OTC Pharmaceuticals: Global Industry Almanac, MarketLine

http://www.reportlinker.com/p0847169/OTC-Pharmaceuticals-Global-Industry-Almanac-MarketLine.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Over-The-

OTC Pharmaceuticals: Global Industry Almanac is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Scope of the Report

* Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies

* Incorporates in-depth five forces competitive environment analysis and scorecards

* Covers the Global, European and Asia-Pacific markets as well as individual chapters on Australia, Belgium, Brazil, Canada, China, Czech Republic, Denmark, France, Germany, Hungary, India, Italy, Japan, Mexico, Netherlands, Norway, Poland, Russia, Singapore, South Africa, South Korea, Spain, Sweden, United Kingdom and United States.

* Includes a five-year forecast of the industry

Highlights

The global OTC pharmaceuticals market grew by 3.6% in 2010 to reach a value of $127,378.9 million.

In 2015, the global OTC pharmaceuticals market is forecast to have a value of $153,081.4 million, an increase of 20.2% since 2010.

Cough and cold preparations is the largest segment of the global OTC pharmaceuticals market, accounting for 18% of the market's total value.

Europe accounts for 36.8% of the global OTC pharmaceuticals market value.

Johnson & Johnson is the leading player in the global OTC pharmaceuticals market, generating a 12.5% share of the market's value.

Why you should buy this report

* Inform your business decisions

* Add weight to presentations and marketing materials

* Save time carrying out entry-level research

Market Definition

The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirinand other analgesics), and medicated skin products (anti-bacteria's, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness). The market is valued according to retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2010 annual average exchange rates.TABLE OF CONTENTSExecutive Summary 2Market value 2Market value forecast 2Category segmentation 2Geography segmentation 2Market share 2Introduction 49What is this report about? 49Who is the target reader? 49How to use this report 49Definitions 49Global OTC Pharmaceuticals 50Market Overview 50Market Data 51Market Segmentation 52Market outlook 57Five forces analysis 58Leading companies 64OTC Pharmaceuticals in Asia-Pacific 75Market Overview 75Market Data 76Market Segmentation 77Market outlook 82Five forces analysis 83Leading companies 89OTC Pharmaceuticals in Europe 99Market Overview 99Market Data 100Market Segmentation 101Market outlook 106Five forces analysis 107Leading companies 113OTC Pharmaceuticals in France 124Market Overview 124Market Data 125Market Segmentation 126Market outlook 131Five forces analysis 132Leading companies 138Macroeconomic indicators 149OTC Pharmaceuticals in Germany 151Market Overview 151Market Data 152Market Segmentation 153Market outlook 158Five forces analysis 159Leading companies 165Macroeconomic indicators 176OTC Pharmaceuticals in Australia 178Market Overview 178Market Data 179Market Segmentation 180Market outlook 185Five forces analysis 186Leading companies 192Macroeconomic indicators 202OTC Pharmaceuticals in Belgium 204Market Overview 204Market Data 205Market Segmentation 206Market outlook 211Five forces analysis 212Leading companies 218Macroeconomic indicators 228OTC Pharmaceuticals in Brazil 230Market Overview 230Market Data 231Market Segmentation 232Market outlook 237Five forces analysis 238Leading companies 244Macroeconomic indicators 254OTC Pharmaceuticals in Canada 256Market Overview 256Market Data 257Market Segmentation 258Market outlook 263Five forces analysis 264Leading companies 270Macroeconomic indicators 278OTC Pharmaceuticals in China 280Market Overview 280Market Data 281Market Segmentation 282Market outlook 287Five forces analysis 288Leading companies 294Macroeconomic indicators 300OTC Pharmaceuticals in The Czech Republic 302Market Overview 302Market Data 303Market Segmentation 304Market outlook 309Five forces analysis 310Leading companies 316Macroeconomic indicators 324OTC Pharmaceuticals in Denmark 326Market Overview 326Market Data 327Market Segmentation 328Market outlook 333Five forces analysis 334Leading companies 340Macroeconomic indicators 350OTC Pharmaceuticals in Hungary 352Market Overview 352Market Data 353Market Segmentation 354Market outlook 359Five forces analysis 360Leading companies 366Macroeconomic indicators 374OTC Pharmaceuticals in India 376Market Overview 376Market Data 377Market Segmentation 378Market outlook 383Five forces analysis 384Leading companies 390Macroeconomic indicators 401OTC Pharmaceuticals in Italy 403Market Overview 403Market Data 404Market Segmentation 405Market outlook 410Five forces analysis 411Leading companies 417Macroeconomic indicators 428OTC Pharmaceuticals in Japan 430Market Overview 430Market Data 431Market Segmentation 432Market outlook 437Five forces analysis 438Leading companies 444Macroeconomic indicators 452OTC Pharmaceuticals in Mexico 454Market Overview 454Market Data 455Market Segmentation 456Market outlook 461Five forces analysis 462Leading companies 468Macroeconomic indicators 480OTC Pharmaceuticals in The Netherlands 482Market Overview 482Market Data 483Market Segmentation 484Market outlook 489Five forces analysis 490Leading companies 496Macroeconomic indicators 507OTC Pharmaceuticals in Norway 509Market Overview 509Market Data 510Market Segmentation 511Market outlook 516Five forces analysis 517Leading companies 523Macroeconomic indicators 531OTC Pharmaceuticals in Poland 533Market Overview 533Market Data 534Market Segmentation 535Market outlook 540Five forces analysis 541Leading companies 547Macroeconomic indicators 553OTC Pharmaceuticals in Russia 555Market Overview 555Market Data 556Market Segmentation 557Market outlook 562Five forces analysis 563Leading companies 569Macroeconomic indicators 578OTC Pharmaceuticals in Singapore 580Market Overview 580Market Data 581Market Segmentation 582Market outlook 587Five forces analysis 588Leading companies 594Macroeconomic indicators 605OTC Pharmaceuticals in South Africa 607Market Overview 607Market Data 608Market Segmentation 609Market outlook 614Five forces analysis 615Leading companies 621Macroeconomic indicators 626OTC Pharmaceuticals in South Korea 628Market Overview 628Market Data 629Market Segmentation 630Market outlook 635Five forces analysis 636Leading companies 642Macroeconomic indicators 650OTC Pharmaceuticals in Spain 652Market Overview 652Market Data 653Market Segmentation 654Market outlook 659Five forces analysis 660Leading companies 666Macroeconomic indicators 676OTC Pharmaceuticals in Sweden 678Market Overview 678Market Data 679Market Segmentation 680Market outlook 685Five forces analysis 686Leading companies 692Macroeconomic indicators 702OTC Pharmaceuticals in The United Kingdom 704Market Overview 704Market Data 705Market Segmentation 706Market outlook 711Five forces analysis 712Leading companies 718Macroeconomic indicators 729OTC Pharmaceuticals in The United States 731Market Overview 731Market Data 732Market Segmentation 733Market outlook 738Five forces analysis 739Leading companies 745Macroeconomic indicators 755Appendix 757Methodology 757